Compass Minerals International, Inc., provides essential minerals in the United States, Canada, the United Kingdom, and internationally. It operates through two segments, Salt and Plant Nutrition. The Salt segment produces, markets, and sells sodium chloride and magnesium chloride, including rock salt, mechanically and solar evaporated salt, and brine and flake magnesium chloride products; and purchases potassium chloride and calcium chloride to sell as finished products or to blend with sodium chloride to produce specialty products. This segment provides products for use as a deicer for roadways, consumer, and professional use; as an ingredient in chemical production; for water treatment, human, and animal nutrition; and for various other consumer and industrial uses, as well as records management services. The Plant Nutrition segment produces sulfate of potash specialty fertilizers in various grades that are used in broadcast spreaders, direct application, and liquid fertilizer solutions under the Protassium+ brand name; turf products used by the turf and ornamental markets, as well as for blends used on golf course greens; organic products; and develops and produces a portfolio of magnesium chloride-based aerial and ground fire retardant products. This segment provides its products to distributors and retailers of crop inputs, as well as growers. The company was formerly known as Salt Holdings Corporation and changed its name to Compass Minerals International, Inc. in December 2003. Compass Minerals International, Inc. was founded in 1844 and is headquartered in Overland Park, Kansas.

Compass Minerals Intl Inc

An update from Cimpress ( ($CMPR) ) is now available. On March 25, 2026, Cimpress plc’s board authorized a new share repurchase program of up to $2...

Cimpress Board Authorizes New $200 Million Share Buyback

In a report released today, Francois Brisebois from LifeSci Capital maintained a Buy rating on COMPASS Pathways, with a price target of $19.00. Bri...

LifeSci Capital Keeps Their Buy Rating on COMPASS Pathways (CMPS)

In a report released on March 24, Leonid Timashev from RBC Capital maintained a Buy rating on COMPASS Pathways, with a price target of $21.00. The ...

RBC Capital Reaffirms Their Buy Rating on COMPASS Pathways (CMPS)

Oppenheimer analyst Jay Olson maintained a Buy rating on COMPASS Pathways today and set a price target of $20.00. Olson covers the Healthcare secto...

Oppenheimer Sticks to Their Buy Rating for COMPASS Pathways (CMPS)

An update from Compass Minerals International ( ($CMP) ) is now available. Compass Minerals International, Inc., a global supplier of salt and plan...

Compass Minerals Accelerates Debt Redemption and Deleveraging Strategy

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abivax SA Sponsored ADR (ABVX), Compass Therapeutics...

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Compass Therapeutics (CMPX) and Talphera (TLPH)

Guggenheim analyst maintained a Buy rating on Compass Therapeutics today and set a price target of $12.00. The word on The Street in general, sugge...

Compass Therapeutics (CMPX) Receives a Buy from Guggenheim

Eurocommercial Properties NV ( ($NL:ECMPA) ) has provided an announcement. Eurocommercial Properties has announced the key dates related to its pro...

Eurocommercial Properties Sets Key Dates for Proposed Dividend

There’s a lot to be optimistic about in the Industrial Goods sector as 3 analysts just weighed in on FedEx (FDX – Research Report), Ducommun (DCO –...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CMP	$25.14	+0.60%	398.87K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CMP	$25.14	+0.6%	398.87K
3
4
5
6

CMP

CMP

Get Compass Minerals Intl Inc Data in Excel

Get Compass Minerals Intl Inc Data in Excel